These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26188238)

  • 61. Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR.
    Toumpanakis C; Garland J; Marelli L; Srirajaskanthan R; Soh J; Davies P; Buscombe J; Caplin ME
    Aliment Pharmacol Ther; 2009 Oct; 30(7):733-40. PubMed ID: 19573169
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcomes of first-line long-acting octreotide treatment in non-functional, advanced gastroenteropancreatic neuroendocrine tumors.
    Saglam S; Hacisahinogullari H; Ozturk N; Kapran Y; Gulluoglu M; Turkmen C; Adalet I; Orhan Bilge A; Cem Balci N
    J BUON; 2015; 20(5):1201-5. PubMed ID: 26537065
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sequential hypoglycemia, hyperglycemia, and the carcinoid syndrome arising from a plurihormonal neuroendocrine neoplasm.
    Mitzner LD; Nohria A; Chacho M; Inzucchi SE
    Endocr Pract; 2000; 6(5):370-4. PubMed ID: 11141588
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Multimodal therapy improved carcinoid syndrome secondary to liver metastases of an atypical lung carcinoid tumor:a case report].
    Shimizu T; Adikrisna R; Shimada K; Uchidate K; Fukuda K; Oyama A; Ueda M; Goto F; Suzuki M; Kawamura T
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(7):635-645. PubMed ID: 32655123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Side effects and complications after hepatic artery embolization in the carcinoid syndrome.
    Kolmannskog F; Kolbenstvedt AN; Schrumpf E; Hanssen LE
    Scand J Gastroenterol; 1991 May; 26(5):557-62. PubMed ID: 1871548
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diabetes Insipidus Induced by Combination of Short-acting Octreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour: A Case Report.
    Guan GK; Rajoo S; Dusa NM; Yahya NHN; Bidin MBL
    J ASEAN Fed Endocr Soc; 2021; 36(2):220-222. PubMed ID: 34966210
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of hepatic arterial embolisation in the carcinoid syndrome.
    Maton PN; Camilleri M; Griffin G; Allison DJ; Hodgson HJ; Chadwick VS
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):932-5. PubMed ID: 6412893
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Embolisation therapy in the midgut carcinoid syndrome: just tumour ischaemia?
    Wängberg B; Geterud K; Nilsson O; Jansson S; Dahlström A; Tylén U; Ahlman H
    Acta Oncol; 1993; 32(2):251-6. PubMed ID: 7686767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases.
    Linch F; Thompson S; Fleming C; Vella A; Andrews J
    J Endocr Soc; 2021 Dec; 5(12):bvab149. PubMed ID: 34877442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of interferons in the management of carcinoid tumors.
    Oberg K; Eriksson B
    Acta Oncol; 1991; 30(4):519-22. PubMed ID: 1854509
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Arterial embolization in the management of liver tumour with recurrent hypoglycaemia.
    Bell GM; Buist TA
    Postgrad Med J; 1981 Aug; 57(670):534-6. PubMed ID: 7301707
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biochemical challenge: difficult management of recurrent hypoglycaemia in the setting of a massive solitary fibrous tumour of the liver.
    Sawka A; Toh D
    Intern Med J; 2018 Jun; 48(6):744-746. PubMed ID: 29898268
    [No Abstract]   [Full Text] [Related]  

  • 73. Long-term symptomatic relief of postprandial hypoglycaemia following gastric surgery with a somatostatin analogue.
    D'Cruz DP; Reynard J; Tatman AJ; Kopelman PG
    Postgrad Med J; 1989 Feb; 65(760):116-7. PubMed ID: 2780462
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The riddle of tumour hypoglycaemia revisited.
    Kahn CR
    Clin Endocrinol Metab; 1980 Jul; 9(2):335-60. PubMed ID: 6994945
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Controlling the carcinoid syndrome.
    Hodgson HJ
    BMJ; 1988 Nov; 297(6658):1213-4. PubMed ID: 2905181
    [No Abstract]   [Full Text] [Related]  

  • 76. Hypoglycaemia. 2. Other causes.
    Marks V
    Clin Endocrinol Metab; 1976 Nov; 5(3):769-82. PubMed ID: 797487
    [No Abstract]   [Full Text] [Related]  

  • 77. Hypothermia as a forgotten sign of prolonged severe hypoglycaemia.
    Naseerullah FS; Murthy A
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30158268
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of carcinoid syndrome.
    Saini A; Waxman J
    Postgrad Med J; 1991 Jun; 67(788):506-8. PubMed ID: 1924020
    [No Abstract]   [Full Text] [Related]  

  • 79. Failure of Ivalon to provide permanent hepatic arterial occlusion.
    Miller DL
    Cardiovasc Intervent Radiol; 1987; 10(2):111-3. PubMed ID: 3107822
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype.
    Kessoku T; Kobayashi N; Yoneda M; Kasai Y; Ozaki A; Okubo N; Iwaki M; Kobayashi T; Yoshihara T; Kurita Y; Honda Y; Tokuhisa M; Ishiki H; Hibiya T; Fujii S; Nakajima A; Ichikawa Y
    Front Oncol; 2020; 10():555963. PubMed ID: 33102220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.